BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20045294)

  • 1. Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli.
    Wu G; Fan X; Li L; Wang H; Ding J; Hongbin W; Zhao R; Gou L; Shen Z; Xi T
    Int J Antimicrob Agents; 2010 Mar; 35(3):250-4. PubMed ID: 20045294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock.
    Hwang YH; Park BK; Lim JH; Kim MS; Park SC; Hwang MH; Yun HI
    Eur J Pharmacol; 2007 Feb; 556(1-3):166-71. PubMed ID: 17126323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of antimicrobial peptide S-thanatin against endotoxic shock in mice introduced by LPS.
    Wu G; Li X; Deng X; Fan X; Wang S; Shen Z; Xi T
    Peptides; 2011 Feb; 32(2):353-7. PubMed ID: 21050874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.
    Wu G; Wu P; Xue X; Yan X; Liu S; Zhang C; Shen Z; Xi T
    Peptides; 2013 Jul; 45():73-7. PubMed ID: 23643614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide.
    Ghiselli R; Giacometti A; Cirioni O; Circo R; Mocchegiani F; Skerlavaj B; D'Amato G; Scalise G; Zanetti M; Saba V
    Shock; 2003 Jun; 19(6):577-81. PubMed ID: 12785015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane aggregation and perturbation induced by antimicrobial peptide of S-thanatin.
    Wu G; Wu H; Li L; Fan X; Ding J; Li X; Xi T; Shen Z
    Biochem Biophys Res Commun; 2010 Apr; 395(1):31-5. PubMed ID: 20331979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of antimicrobial peptide S-thanatin is independent on multidrug-resistant spectrum of bacteria.
    Wu G; Li X; Fan X; Wu H; Wang S; Shen Z; Xi T
    Peptides; 2011 Jun; 32(6):1139-45. PubMed ID: 21453736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.
    Szabo D; Ostorhazi E; Binas A; Rozgonyi F; Kocsis B; Cassone M; Wade JD; Nolte O; Otvos L
    Int J Antimicrob Agents; 2010 Apr; 35(4):357-61. PubMed ID: 20031377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR based structure-activity relationship analysis of an antimicrobial peptide, thanatin, engineered by site-specific chemical modification: Activity improvement and spectrum alteration.
    Imamura T; Yamamoto N; Tamura A; Murabayashi S; Hashimoto S; Shimada H; Taguchi S
    Biochem Biophys Res Commun; 2008 May; 369(2):609-15. PubMed ID: 18294955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective toxicity of antimicrobial peptide S-thanatin on bacteria.
    Wu G; Wu H; Fan X; Zhao R; Li X; Wang S; Ma Y; Shen Z; Xi T
    Peptides; 2010 Sep; 31(9):1669-73. PubMed ID: 20600431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
    Lee JW; Paape MJ; Zhao X
    Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; D'Amato G; Sisti V; Scalise G; Saba V
    Ann Surg; 2004 Feb; 239(2):251-6. PubMed ID: 14745334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli.
    Lee JK; Seo CH; Luchian T; Park Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):495-506. PubMed ID: 26552969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties.
    Bruschi M; Pirri G; Giuliani A; Nicoletto SF; Baster I; Scorciapino MA; Casu M; Rinaldi AC
    Peptides; 2010 Aug; 31(8):1459-67. PubMed ID: 20438783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.